Immunic
IMUX
IMUX
73 hedge funds and large institutions have $63.4M invested in Immunic in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 26
68% less capital invested
Capital invested by funds: $198M → $63.4M (-$135M)
Holders
73
Holding in Top 10
2
Calls
$3.66M
Puts
$2.56M
Top Buyers
1 | +$3.83M | |
2 | +$2.13M | |
3 | +$2.08M | |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.08M |
5 |
Janus Henderson Group
London,
United Kingdom
|
+$1.76M |
Top Sellers
1 | -$7.72M | |
2 | -$6.59M | |
3 | -$3.39M | |
4 |
BlackRock
New York
|
-$2.92M |
5 |
OCA
Otter Creek Advisors
Palm Beach Gardens,
Florida
|
-$1.6M |